 | |||||
| cannabidiol for epilepsy | |||||
| NEWS | |||||
| Lexaria Announces R&D Program to Compare First and Only FDA-Approved Prescription ... ... Epidiolex to DehydraTECHTM-CBD for reducing seizure activity ... forms of paediatric epilepsy, Lennox-Gastaut syndrome and Dravet syndrome.
| |||||
| Lexaria Announces DehydraTECH-CBD Versus Prescription CBD Program In Treating Seizures ... is the first and only FDA-approved CBD medication for seizures associated with two rare and severe forms of pediatric epilepsy.
| |||||
| Lexaria Bioscience (LEXX) Announces R&D Program to Compare First and Only FDA ... ... inhibit seizure activity compared to both generic cannabidiol ("CBD") ... of paediatric epilepsy, Lennox-Gastaut syndrome and Dravet syndrome.
| |||||
| See more results | Edit this alert | |||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
